These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 16338223)
1. Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor. Adachi T; Matsushita T; Dong Z; Katsumi A; Nakayama T; Kojima T; Saito H; Sadler JE; Naoe T Biochem Biophys Res Commun; 2006 Jan; 339(4):1178-83. PubMed ID: 16338223 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis. Kroner PA; Frey AB Biochemistry; 1996 Oct; 35(41):13460-8. PubMed ID: 8873615 [TBL] [Abstract][Full Text] [Related]
3. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor. Matsushita T; Sadler JE J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426 [TBL] [Abstract][Full Text] [Related]
4. ASP514 within the A1 domain of bovine von Willebrand factor is required for interaction with platelet glycoprotein Ib. Sinha D; Bakhshi M; Kunapuli S; Vora R; Gabriel JL; Kirby EP; Budzynski AZ Biochem Biophys Res Commun; 1994 Sep; 203(2):881-8. PubMed ID: 8093071 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727 [TBL] [Abstract][Full Text] [Related]
6. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations. Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314 [TBL] [Abstract][Full Text] [Related]
7. Primary binding domain of bovine von Willebrand factor fragment expressed in E. coli. Bakhshi MR; Sinha D; Vora RK; Budzynski AZ; Kirby EP Thromb Haemost; 1996 Jan; 75(1):196-202. PubMed ID: 8713801 [TBL] [Abstract][Full Text] [Related]
8. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation. Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170 [TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of the seven tandem leucine-rich repeats within the ligand-binding region of platelet glycoprotein Ib alpha. Whisstock JC; Shen Y; López JA; Andrews RK; Berndt MC Thromb Haemost; 2002 Feb; 87(2):329-33. PubMed ID: 11858495 [TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. O'Seaghdha M; van Schooten CJ; Kerrigan SW; Emsley J; Silverman GJ; Cox D; Lenting PJ; Foster TJ FEBS J; 2006 Nov; 273(21):4831-41. PubMed ID: 16999823 [TBL] [Abstract][Full Text] [Related]
11. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction. Schulte am Esch J; Robson SC; Knoefel WT; Eisenberger CF; Peiper M; Rogiers X Br J Haematol; 2005 Jan; 128(1):82-90. PubMed ID: 15606553 [TBL] [Abstract][Full Text] [Related]
12. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340 [TBL] [Abstract][Full Text] [Related]
13. Two clusters of charged residues located in the electropositive face of the von Willebrand factor A1 domain are essential for heparin binding. Rastegar-Lari G; Villoutreix BO; Ribba AS; Legendre P; Meyer D; Baruch D Biochemistry; 2002 May; 41(21):6668-78. PubMed ID: 12022870 [TBL] [Abstract][Full Text] [Related]
14. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Schulte Am Esch J; Robson SC; Knoefel WT; Hosch SB; Rogiers X Xenotransplantation; 2005 Jan; 12(1):30-7. PubMed ID: 15598271 [TBL] [Abstract][Full Text] [Related]
15. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. Kang M; Wilson L; Kermode JC Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030 [TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis. Nakayama T; Matsushita T; Yamamoto K; Mutsuga N; Kojima T; Katsumi A; Nakao N; Sadler JE; Naoe T; Saito H Int J Hematol; 2008 May; 87(4):363-370. PubMed ID: 18369690 [TBL] [Abstract][Full Text] [Related]
17. Conformational stability and domain unfolding of the Von Willebrand factor A domains. Auton M; Cruz MA; Moake J J Mol Biol; 2007 Feb; 366(3):986-1000. PubMed ID: 17187823 [TBL] [Abstract][Full Text] [Related]
19. Surface-dependent expression in the platelet GPIb binding domain within human von Willebrand factor studied by atomic force microscopy. Kang I; Raghavachari M; Hofmann CM; Marchant RE Thromb Res; 2007; 119(6):731-40. PubMed ID: 17010412 [TBL] [Abstract][Full Text] [Related]
20. [Structure and function of the factor VIII/von Willebrand factor complex]. Müller G Z Gesamte Inn Med; 1990 Mar; 45(3):65-8. PubMed ID: 2159676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]